Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means HIMS: Regulatory Arbitrage and the Future of Personalized Medicine The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step BPC 157 Context: About two hours ago, Bobby Kennedy said that the FDA is removing 14 peptides from this list. That means that compounding pharmacies are going to be able to compound a lot